Related Pages for UPL
- Option Chain
- Straddle OC
- Max Pain
- Put Call Ratio
- Option Analytics
- Call OI vs Put OI
- Strike Flow
- Call OI Chg vs Put OI Chg
- Call Vol vs Put Vol
- Buildup & Unwinding
- Vega Divergence
- Multi Strike OI
- Multi Straddle Analysis
- Price vs OI
- Time Series Table
- Time Series Multi Chart
- Volatility Skew
- Premium Decay
- IV - HV
- IV Intraday
- Future Chain
- Future Intraday Analysis
- Technical
- Financials
- Chart
- About
No results found.
Related News - UPL
UPL: DAM Capital on UPL Maintains Buy with Target Price of ₹870 as Advanta grows 20%+, Superform’s specialty chemicals grew 51% in Q1 and group EBITDA rose 15% on 10% revenue growth, while the 61% HoldCo discount appears excessive and the Advanta IPO could unlock value.
27 Aug 2026 08:55 AM
UPL: DAM Capital on UPL Maintains Buy with Target Price of ₹870 as Advanta grows 20%+, Superform’s specialty chemicals grew 51% in Q1 and group EBITDA rose 15% on 10% revenue growth, while the 61% HoldCo discount appears excessive and the Advanta IPO could unlock value.
UPL: Group COO Toshan Tamhane Resigns To Pursue Entrepreneurial Ventures; Effective From August 31, 2026.
26 Aug 2026 03:42 PM
UPL: Group COO Toshan Tamhane Resigns To Pursue Entrepreneurial Ventures; Effective From August 31, 2026.
India Government Prohibits Imports, Sale, Manufacturing, And Distribution Of Carbosulfan Insecticide (UPL)
25 Aug 2026 11:56 AM
India Government Prohibits Imports, Sale, Manufacturing, And Distribution Of Carbosulfan Insecticide (UPL)
UPL: Jefferies on UPL Buy, Target Price Rs 715, citing confidence in 10–14% FY27 growth guidance, expected EBITDA margin improvement from rationalising unprofitable businesses, tight LatAm inventory control amid El Niño, upcoming Advanta IPO marketing and projected 14% FY27E EBITDA growth.
25 Aug 2026 08:57 AM
UPL: Jefferies on UPL Buy, Target Price Rs 715, citing confidence in 10–14% FY27 growth guidance, expected EBITDA margin improvement from rationalising unprofitable businesses, tight LatAm inventory control amid El Niño, upcoming Advanta IPO marketing and projected 14% FY27E EBITDA growth.
UPL: Advanta BV, a subsidiary, buys 99.98% of Misr Hy Tech Seed International for around $110 million.
15 Aug 2026 02:21 PM
UPL: Advanta BV, a subsidiary, buys 99.98% of Misr Hy Tech Seed International for around $110 million.
UPL: HSBC on UPL Maintains Buy with Target Price of ₹880 as resilient Q1FY27 performance across businesses, FY27 EBITDA growth guidance of 10–14%, restructuring progress on track, and attractive FY28 valuation support outlook.
04 Aug 2026 08:59 AM
UPL: HSBC on UPL Maintains Buy with Target Price of ₹880 as resilient Q1FY27 performance across businesses, FY27 EBITDA growth guidance of 10–14%, restructuring progress on track, and attractive FY28 valuation support outlook.
UPL: DAM Capital on UPL Maintains Buy with Target Price of ₹870 as FY27 guidance of 7–11% revenue growth and 10–14% EBITDA growth, restructuring milestones, Advanta IPO progress, crop protection reorganization, and margin focus offset cautious demand outlook.
04 Aug 2026 08:59 AM
UPL: DAM Capital on UPL Maintains Buy with Target Price of ₹870 as FY27 guidance of 7–11% revenue growth and 10–14% EBITDA growth, restructuring milestones, Advanta IPO progress, crop protection reorganization, and margin focus offset cautious demand outlook.
UPL: Jefferies on UPL Maintains Buy with Target Price of ₹715 as despite EBITDA and PAT missing estimates, FY27 guidance of 7–11% revenue growth and 10–14% EBITDA growth, 21% stock correction, and expected 14% FY27 EBITDA growth support the outlook.
04 Aug 2026 08:59 AM
UPL: Jefferies on UPL Maintains Buy with Target Price of ₹715 as despite EBITDA and PAT missing estimates, FY27 guidance of 7–11% revenue growth and 10–14% EBITDA growth, 21% stock correction, and expected 14% FY27 EBITDA growth support the outlook.
UPL: Guidance - UPL delivered on its Q1 guidance and expects full-year FY27 revenue growth of 7% to 11% and EBITDA growth of 10% to 14%.- Concall Update
04 Aug 2026 08:56 AM
UPL: Guidance - UPL delivered on its Q1 guidance and expects full-year FY27 revenue growth of 7% to 11% and EBITDA growth of 10% to 14%.- Concall Update
UPL: Guidance - Management is confident in delivering a strong Q2 and meeting full-year commitments, with growth expected to be volume-led for the remainder of the year.- Concall Update
04 Aug 2026 08:56 AM
UPL: Guidance - Management is confident in delivering a strong Q2 and meeting full-year commitments, with growth expected to be volume-led for the remainder of the year.- Concall Update
UPL: Guidance - The seeds and super specialty businesses are expected to continue strong growth, with India's business performance dependent on monsoon conditions.- Concall Update
04 Aug 2026 08:56 AM
UPL: Guidance - The seeds and super specialty businesses are expected to continue strong growth, with India's business performance dependent on monsoon conditions.- Concall Update
UPL: Guidance - For global crop protection, volume recovery is anticipated as growers will use necessary products, and UPL aims for market share growth.- Concall Update
04 Aug 2026 08:56 AM
UPL: Guidance - For global crop protection, volume recovery is anticipated as growers will use necessary products, and UPL aims for market share growth.- Concall Update
UPL: Guidance - The company expects to achieve $115 million in revenue from new product launches this year and anticipates improved EBITDA margins for the full year.- Concall Update
04 Aug 2026 08:56 AM
UPL: Guidance - The company expects to achieve $115 million in revenue from new product launches this year and anticipates improved EBITDA margins for the full year.- Concall Update
UPL: FY27 EBITDA GROWTH GUIDANCE OF 10-14%
03 Aug 2026 03:26 PM
UPL: FY27 EBITDA GROWTH GUIDANCE OF 10-14%
UPL: FY27 REVENUE GROWTH GUIDANCE OF 7-11%
03 Aug 2026 03:27 PM
UPL: FY27 REVENUE GROWTH GUIDANCE OF 7-11%
UPL: Q1 CONS NET PROFIT 100M RUPEES VS LOSS 880M (YOY)
03 Aug 2026 03:18 PM
UPL: Q1 CONS NET PROFIT 100M RUPEES VS LOSS 880M (YOY)
UPL: Q1 EBITDA 14.5B RUPEES VS 13.96B (YOY) || Q1 EBITDA MARGIN 14.24% VS 15.15% (YOY)
03 Aug 2026 03:19 PM
UPL: Q1 EBITDA 14.5B RUPEES VS 13.96B (YOY) || Q1 EBITDA MARGIN 14.24% VS 15.15% (YOY)
UPL: Q1 REVENUE 102B RUPEES VS 92B (YOY)
03 Aug 2026 03:19 PM
UPL: Q1 REVENUE 102B RUPEES VS 92B (YOY)
UPL: Subsidiary UPL Brasil Gets Green Light to Sell Full Stake in Bioplanta JV
29 Jul 2026 08:39 PM
UPL: Subsidiary UPL Brasil Gets Green Light to Sell Full Stake in Bioplanta JV
Govt Bans Permanent Sale Of Paraquat Dichloride || Upl Has Good Portfilio In Paraquat - Govt Order
15 Jul 2026 01:08 PM
Govt Bans Permanent Sale Of Paraquat Dichloride || Upl Has Good Portfilio In Paraquat - Govt Order